Narrow Results By
CMA response to patented medicines regulations consultations
https://policybase.cma.ca/link/policy13690
Non-prescription availability of low-dose codeine products
https://policybase.cma.ca/link/policy13734
Excise duty framework for cannabis products
https://policybase.cma.ca/link/policy13799
Consultation on the renewal of Federal Tobacco Control Strategy
https://policybase.cma.ca/link/policy13804
- Date
- 2017-04-05
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs